ATE270558T1 - Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien - Google Patents

Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien

Info

Publication number
ATE270558T1
ATE270558T1 AT00964921T AT00964921T ATE270558T1 AT E270558 T1 ATE270558 T1 AT E270558T1 AT 00964921 T AT00964921 T AT 00964921T AT 00964921 T AT00964921 T AT 00964921T AT E270558 T1 ATE270558 T1 AT E270558T1
Authority
AT
Austria
Prior art keywords
emu oil
microbial
topical application
therapeutic
emu
Prior art date
Application number
AT00964921T
Other languages
English (en)
Inventor
Sean Farmer
Original Assignee
Ganeden Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ganeden Biotech Inc filed Critical Ganeden Biotech Inc
Application granted granted Critical
Publication of ATE270558T1 publication Critical patent/ATE270558T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT00964921T 1999-08-26 2000-08-25 Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien ATE270558T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38404399A 1999-08-26 1999-08-26
PCT/US2000/023448 WO2001013956A2 (en) 1999-08-26 2000-08-25 Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications

Publications (1)

Publication Number Publication Date
ATE270558T1 true ATE270558T1 (de) 2004-07-15

Family

ID=23515789

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00964921T ATE270558T1 (de) 1999-08-26 2000-08-25 Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien

Country Status (8)

Country Link
US (5) US6531126B2 (de)
EP (1) EP1212093B1 (de)
JP (1) JP2003507437A (de)
AT (1) ATE270558T1 (de)
CA (1) CA2382670A1 (de)
DE (1) DE60012026T2 (de)
ES (1) ES2221624T3 (de)
WO (1) WO2001013956A2 (de)

Families Citing this family (161)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716435B1 (en) * 1997-04-18 2004-04-06 Ganeden Biotech, Inc. Absorbent product containing absorbent structure and Bacillus coagulans
ATE493139T1 (de) * 1997-04-18 2011-01-15 Ganeden Biotech Inc Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
US6461607B1 (en) * 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
EP1212093B1 (de) * 1999-08-26 2004-07-07 Ganeden Biotech, Inc. Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien
HU230030B1 (hu) 1999-10-08 2015-05-28 Debiopharm International Sa Fab I inhibitorok
US6849256B1 (en) 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
SE518097C2 (sv) 2000-10-03 2002-08-27 Ellen Ab Förfarande för framställning av en absorberande sanitetsartikel som innefattar mjölksyraproducerande bakterier samt sådant alster
KR100743404B1 (ko) 2000-12-21 2007-07-30 넥타르 테라퓨틱스 폴리엔 항균제의 폐 전달
US6528040B1 (en) * 2001-01-18 2003-03-04 Maurine Pearson EMU oil-based formulations for use as an analgesic, anesthetic and antipruritic
EP1560584B1 (de) * 2001-04-06 2009-01-14 Affinium Pharmaceuticals, Inc. Fab-i-inhibitoren
IL142537A0 (en) * 2001-04-11 2002-03-10 Yeda Res & Dev Pharmaceutical compositions for the treatment of autoimmune diseases
US20090123606A1 (en) * 2001-05-25 2009-05-14 Frank Corsini Carbohydrate modifying agent and drinks containing the modifying agent
US9101148B2 (en) * 2001-05-25 2015-08-11 Sbs Food Group Llc Carbohydrate modifying agent and drinks containing the modifying agent
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
US6878373B2 (en) * 2001-12-03 2005-04-12 Micropure Technologies, Inc. Probiotic composition containing Bacillus cereus RRRL B-30535
SE0104199L (sv) * 2001-12-13 2003-06-14 Sca Hygiene Prod Ab Ny produkt
US20030143262A1 (en) 2001-12-13 2003-07-31 Brusk Ulla Forsgren Hygiene tissue
WO2003086274A2 (en) * 2002-04-18 2003-10-23 Right After - Advanced Hygiene Solutions Ltd. A compound for cleansing the skin and a product impregnated therewith
US20060216267A1 (en) * 2002-08-20 2006-09-28 Kovacs Stephen G Hydrophobic elastomeric polymer chemistry device for inhibiting the growth of onychomycosis and urushiol-induced allergic contact dermatitis
CA2495923A1 (en) * 2002-08-20 2004-03-04 Doren M. Pinnell Methods for treating fungal infections
US8404751B2 (en) * 2002-09-27 2013-03-26 Hallux, Inc. Subunguicide, and method for treating onychomycosis
US20070014743A1 (en) * 2002-09-27 2007-01-18 Birnbaum Jay E Subunguicide, and method for treating onychomycosis
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
DE10251301A1 (de) * 2002-11-03 2004-05-13 Roßmeier, Martin Lokal auf die Haut aufzutragendes Mittel
EP1575951B1 (de) * 2002-12-06 2014-06-25 Debiopharm International SA Heterozyclische verbindungen, verfahren zu deren herstellung und ihre verwendung als heilmittel
US20060166879A1 (en) * 2002-12-20 2006-07-27 Chakshu Research Inc Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders
US20060172972A1 (en) * 2002-12-20 2006-08-03 Chakshu Research Inc Formulation and method for administration of ophthalmologically active agents
US7482023B2 (en) 2003-01-03 2009-01-27 Sca Hygiene Products Ab Hygiene tissue with lactic acid producing bacterial strains
SE525647C2 (sv) * 2003-01-03 2005-03-29 Sca Hygiene Prod Ab Hygientissue för rengöring av och överföring av mjölksyraproducerande bakterier till huden och det urogenitila området
ATE513551T1 (de) * 2003-01-24 2011-07-15 Flora Technology Inc Zusammensetzungen und verfahren zur wiederherstellung der bakterienflora
WO2004082586A2 (en) * 2003-03-17 2004-09-30 Affinium Pharmaceuticals, Inc. Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
US7052715B2 (en) 2003-04-11 2006-05-30 All Natural Fmg, Inc. Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof
US7033998B2 (en) 2003-04-11 2006-04-25 All Natural Fmg, Inc. Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
SE526029C2 (sv) * 2003-05-13 2005-06-21 Sca Hygiene Prod Ab Hygien produkt innefattande bakteriepreparation och förfarande för dess framställning
SE526982C2 (sv) * 2003-05-27 2005-11-29 Sca Hygiene Prod Ab Enskiktspolymermatrisfilm innefattande mjölksyraproducerande bakterier, framställning samt användning därav
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
WO2005026193A2 (en) * 2003-09-08 2005-03-24 United States Army Medical Research And Materiel Command Small molecules and a pharmacophore model for inhibition of botulinum toxin and methods of making and using thereof
CN101829319A (zh) 2003-12-08 2010-09-15 Cpex药品公司 用于胰岛素治疗的药用组合物及方法
US7029711B2 (en) * 2003-12-09 2006-04-18 Shannon Lynn Farrell Mixture of and method of making a trancutaneous pain relief composition
US7807622B2 (en) * 2004-04-23 2010-10-05 Health Enhancement Products, Inc. Composition and use of phyto-percolate for treatment of disease
US10166270B2 (en) 2004-04-23 2019-01-01 Zivo Bioscience, Inc. Composition and method for affecting cytokines and NF-κB
US7854927B2 (en) * 2004-05-11 2010-12-21 Ganeden Biotech, Inc. Methods and compositions for the dietary management of autoimmune disorders
US7374750B2 (en) * 2004-05-14 2008-05-20 Jennifer Albano Probiotic containing anhydrous hair care composition
DK1828167T3 (da) * 2004-06-04 2014-10-20 Debiopharm Int Sa Acrylamidderivater som antibiotiske midler
CN101065132A (zh) 2004-07-28 2007-10-31 雷蒙德·M·普莱瓦 鸸鹋油和水果组合物
US9028852B2 (en) * 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US20060147423A1 (en) * 2004-12-07 2006-07-06 Jean-Yves Legendre Transungual device
US20060251593A1 (en) * 2005-04-07 2006-11-09 Work By Docs, Inc. Colored nail enamel treatment
EP1928247A4 (de) * 2005-04-20 2009-10-28 Health Enhancement Products In Zusammensetzung und verwendung von phytopercolat zur behandlung von krankheiten
EP1906754A4 (de) * 2005-05-31 2009-03-11 Limited Wockhardt Neue zusatzstoffe für geflügel und nutztiere
US20070009607A1 (en) * 2005-07-11 2007-01-11 George Jones Antibacterial/anti-infalmmatory composition and method
DE502006009212D1 (de) * 2005-07-15 2011-05-12 Stefano Bardazzi Pharmazeutische zusammensetzung zur behandlung von xerostomie
US20070094893A1 (en) * 2005-09-02 2007-05-03 Veronica Flores Disposable flip-flop with exfoliating and moisturizing functions
WO2007033082A2 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Compositions comprising dimethyl sulfoxide (dmso)
US8435224B2 (en) 2005-09-12 2013-05-07 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
AU2006291134C1 (en) 2005-09-12 2013-08-15 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (DMSO) or related compounds, or odors associated with same
US8586053B2 (en) * 2005-09-21 2013-11-19 Health Enhancement Products, Inc. Composition and use of phyto-percolate for treatment of disease
US20080220103A1 (en) * 2005-10-24 2008-09-11 Jay Birnbaum Method for treating/controlling/killing fungi and bacteria on living animals
US20070116778A1 (en) * 2005-11-22 2007-05-24 Fierro Arthur A Antibacterial, antiviral, and antifungal nutritional supplement: a combination of natural or neutraceutical compounds shown to have antibacterial, antiviral, and antifungal properties, to help boost the immune system in humans, and to protect against certain biowarfare diseases
KR20080075027A (ko) * 2005-12-05 2008-08-13 아피늄 파마슈티컬스, 인크. Ｆａｂｉ 억제제 및 항박테리아제로서의헤테로시클릴아크릴아미드 화합물
WO2007073264A1 (en) * 2005-12-22 2007-06-28 Sca Hygiene Products Ab Absorbent article
EP1965839B1 (de) 2005-12-22 2012-07-25 SCA Hygiene Products AB Saugfähiger artikel
JP5199551B2 (ja) * 2006-07-06 2013-05-15 サンスター株式会社 カンジダ菌感染に基づく疾患の予防又は改善剤
JP5468899B2 (ja) 2006-07-20 2014-04-09 アフィニウム ファーマシューティカルズ， インク． Ｆａｂｉインヒビターとしてのアクリルアミド誘導体
KR100806051B1 (ko) * 2006-09-06 2008-02-26 오교철 답손을 유효성분으로 함유하는 항진균용 약학 조성물
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
CN109010900A (zh) * 2006-11-17 2018-12-18 Sca卫生用品公司 包含微生物抑制性组合物的卫生织物
AU2006350771B2 (en) * 2006-11-17 2012-12-06 Sca Hygiene Products Ab Lactobacillus fermentum Ess-1, DSM17851 and its use for the treatment and/or prevention of candidiasis and urinary tracrinfections
CN101657221A (zh) 2006-11-17 2010-02-24 Sca卫生用品公司 包含微生物抑制性组合物的卫生用品
CA2673409A1 (en) * 2006-12-19 2009-06-26 Ferrosan A/S Wound or tissue dressing comprising lactic acid bacteria
EP2125802A4 (de) 2007-02-16 2014-08-20 Debiopharm Int Sa Salze, prodrugs und polymorphe von fab-i-inhibitoren
US20080255103A1 (en) * 2007-04-12 2008-10-16 Ballay Pharmaceuticals, Inc. Antihistamine and anti-nausea pharmaceutical compositions for topical application
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
CN101678147A (zh) * 2007-06-21 2010-03-24 Sca卫生用品公司 亲水性载体中含乳酸杆菌的卫生用品
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
EP3628164A1 (de) 2007-08-29 2020-04-01 Ganeden Biotech, Inc. Backwaren
ES2868135T3 (es) * 2007-10-16 2021-10-21 Ganeden Biotech Inc Composiciones de bebidas
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US9314524B2 (en) * 2007-12-31 2016-04-19 Calla Therapeutics Llc Topical formulations of Flucytosine
WO2009099562A2 (en) * 2008-01-30 2009-08-13 Ganeden Biotech, Inc. Compositions and methods for cleaning surfaces
WO2009106087A1 (fr) * 2008-02-25 2009-09-03 Kamel Belhocine Un medicament a usage dermique pour traiter les dermatophyties
CA2716872C (en) 2008-02-29 2015-02-10 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US7788209B2 (en) * 2008-05-05 2010-08-31 United Technologies Corporation Hybrid fault reasoning and guided troubleshooting system that uses case-based reasoning and model-based reasoning
CA2740423C (en) 2008-10-16 2020-09-08 Ganeden Biotech, Inc. Probiotic grain-based compositions
BRPI0921494A2 (pt) 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
EP2424550B1 (de) * 2009-04-29 2017-06-07 Ganeden Biotech, Inc. Bakterienzellmembran formulierung
WO2010128906A1 (en) * 2009-05-06 2010-11-11 Sca Hygiene Products Ab Sanitary article with probiotic effect
US8506952B2 (en) * 2009-07-03 2013-08-13 James Madison Innovations, Inc. Probiotic compositions and process thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011064631A1 (en) 2009-10-02 2011-06-03 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
AU2010313228B2 (en) * 2009-10-30 2014-05-29 Biogenic Innovations, Llc Methylsulfonylmethane (MSM) for treatment of drug resistant microorganisms
US9839609B2 (en) 2009-10-30 2017-12-12 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
CA2780144A1 (en) * 2009-11-16 2011-05-19 Health Enhancement Products, Inc. Use of an extract derived from atcc #pta-5863 as an anti-inflammatory and anti-viral agent
EP2338476B1 (de) * 2009-12-02 2012-06-20 Bettina Heil Zäpfchen zur rektalen, vaginalen oder urethralen Verabreichung mit einem Probiotik, einem Antibiotikum und einer ungesättigten nicht-veresterten Fettsäure
CA2827401A1 (en) 2010-02-22 2011-08-25 Health Enhancement Products, Inc. Agents and mechanisms for treating hypercholesterolemia
WO2011130487A1 (en) 2010-04-14 2011-10-20 Ganeden Biotech, Inc. Probiotic confection and lipid compositions
FR2967070B1 (fr) * 2010-11-05 2013-07-05 Oreal Acide gras monoinsature pour prevenir et/ou traiter les imperfections du teint de la peau
US8846740B2 (en) 2011-01-04 2014-09-30 Biological Responsibility, Llc Biotherapeutics for the treatment of infectious diseases
WO2012135499A1 (en) 2011-03-31 2012-10-04 Ganeden Biotech, Inc. Probiotic sports nutrition compositions
US9138446B2 (en) 2011-06-08 2015-09-22 Scott Alan Weisenfluh EMU oil in combination with other active ingredients for treating skin imperfections
US10471131B2 (en) 2012-01-19 2019-11-12 Hybrid Medical, Llc Topical therapeutic formulations
US9333242B2 (en) * 2012-01-19 2016-05-10 Hybrid Medical, Llc Topical therapeutic formulations
WO2013130829A1 (en) * 2012-02-28 2013-09-06 Ganeden Biotech, Inc. Cosmetic compositions
US20150044317A1 (en) * 2012-02-28 2015-02-12 Ganeden Biotech, Inc. Topical Compositions for Reducing Visible Signs of Aging and Methods of Use Thereof
CN104159527B (zh) 2012-03-06 2017-04-12 弗罗桑医疗设备公司 包含止血糊剂的压力容器
GB201206599D0 (en) * 2012-04-13 2012-05-30 Univ Manchester Probiotic bacteria
WO2013158319A1 (en) * 2012-04-16 2013-10-24 Zemtsov Enterprises, Llc Formulations and methods for treatment of wounds and inflammatory skin conditions
RU2636240C2 (ru) 2012-06-12 2017-11-21 Ферросан Медикал Дивайсиз А/С Сухая гемостатическая композиция
AU2013279021C1 (en) 2012-06-19 2017-03-16 Debiopharm International Sa Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
US10302630B2 (en) 2012-10-09 2019-05-28 The Procter & Gamble Company Method of identifying or evaluating beneficial actives and compositions containing the same
JP6189962B2 (ja) 2012-10-09 2017-08-30 ザ プロクター アンド ギャンブル カンパニー 相乗作用する美容成分の組み合わせを特定する方法
US9138393B2 (en) 2013-02-08 2015-09-22 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin
US9144538B2 (en) 2013-02-08 2015-09-29 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin
EA201591755A1 (ru) 2013-03-14 2016-03-31 3 ИН 1 ДЕНТАЛ ПиЭлЭлСи Композиции для лечения ксеростомии и для лечения зубов
CN105377355A (zh) 2013-03-14 2016-03-02 拇趾公司 治疗甲单元的感染、疾病或病症的方法
US10232028B2 (en) 2013-06-13 2019-03-19 Zivo Bioscience, Inc. Compounds and methods for affecting cytokines
JP6390873B2 (ja) 2013-06-21 2018-09-19 フェッローサン メディカル ディバイス エー／エス 減圧膨張させた乾燥組成物およびそれを保持するためのシリンジ
US9596861B2 (en) 2013-12-24 2017-03-21 Sami Labs Limited Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof
RU2705905C2 (ru) 2014-12-24 2019-11-12 Ферросан Медикал Дивайсиз А/С Шприц для удерживания и смешивания первого и второго веществ
EP3258948B1 (de) 2015-02-16 2023-12-06 Zivo Bioscience, Inc. Anti-entzündliche und immunomodulatorische zusammensetzungen, enthaltend klebsormidium und verwendungen davon
EP3307871A2 (de) * 2015-06-11 2018-04-18 Biomimetx, S.A. Aus einer pseudomonas pf-11-kultur hergestellte antifouling-zusammensetzung
CA2986981A1 (en) 2015-07-03 2017-01-12 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
WO2017142906A1 (en) 2016-02-16 2017-08-24 Zivo Bioscience, Inc. Nutritional support for animals via administration of an algal derived supplement
RS61312B1 (sr) 2016-02-26 2021-02-26 Debiopharm Int Sa Lek za lečenje infekcija dijabetskog stopala
BE1023643B1 (nl) 2016-03-21 2017-06-01 Yun NV Vaginale preparaten voor het onderhouden en / of herstellen van een gezonde vrouwelijke microbiota
WO2017173240A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
EP3436041B1 (de) 2016-03-31 2023-05-24 Gojo Industries, Inc. Zusammensetzung zur desinfektion, enthaltend einen probiotischen/prebiotischen bestandteil
AU2017240064B8 (en) 2016-03-31 2021-11-11 Gojo Industries, Inc. Antimicrobial peptide stimulating sanitizing composition
BE1024425B9 (nl) * 2016-06-21 2018-03-26 Yun NV Dermatologische preparaten voor het onderhouden en/of herstellen van een gezonde huidmicrobiota
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
JP2020500860A (ja) 2016-11-23 2020-01-16 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティック／プレバイオティックな有効成分を含む消毒薬組成物
JP2020508357A (ja) * 2017-02-27 2020-03-19 コンティニュアム グループ エルエルシー 日焼け止め剤
US11123382B2 (en) * 2017-06-06 2021-09-21 Sami Labs Limited Hair care compositions containing extracellular metabolite preparation from Bacillus coagulans
CN111093622A (zh) * 2017-06-06 2020-05-01 萨米莱布斯有限公司 来自凝结芽孢杆菌的胞外代谢物的皮肤护理应用
EP4321182A3 (de) 2018-05-09 2024-05-29 Ferrosan Medical Devices A/S Verfahren zur herstellung einer hämostatischen zusammensetzung
WO2019227034A1 (en) * 2018-05-25 2019-11-28 Locus Ip Company, Llc Therapeutic compositions for enhanced healing of wounds and scars
TN2021000159A1 (en) 2019-02-14 2023-04-04 Debiopharm Int Sa Afabicin formulation, method for making the same and uses thereof
SG11202111168UA (en) 2019-04-09 2021-11-29 Dermbiont Inc Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes
WO2020234382A1 (en) * 2019-05-20 2020-11-26 Lactobio Aps Composition for treatment, alleviation or prophylaxis of acne
SG11202113174SA (en) 2019-06-14 2021-12-30 Debiopharm Int Sa Medicament and use thereof for treating bacterial infections involving biofilm
US11124438B2 (en) 2020-01-20 2021-09-21 Chio Kang Medical, Inc. Alcaligenes faecalis for degrading ethylene oxide
US11220667B2 (en) 2020-01-20 2022-01-11 Chio Kang Medical, Inc. Bacteria for degrading ethylene oxide and applications thereof
US11130939B2 (en) 2020-01-20 2021-09-28 Chio Kang Medical, Inc. Bacteria for degrading ethylene oxide and uses thereof
US11085016B1 (en) 2020-01-20 2021-08-10 Chio Kang Medical, Inc. Method for screening bacteria capable of degrading ethylene oxide
CN114573192B (zh) * 2022-03-28 2023-04-07 纪福林 一种污水及固废全域处理系统及其方法
DE202022001251U1 (de) 2022-05-11 2022-07-19 Pharmachem Pößneck GmbH & Co. KG Pharmazeutisches Hautpflegemittel

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4062943A (en) 1974-11-20 1977-12-13 Board Of Supervisors Louisiana State University A & M Antibiotic produced from the microorganism (Pseudomonas lindbergii), its preparation and method of use
US4323651A (en) * 1974-12-04 1982-04-06 R. J. Reynolds Tobacco Company Thermostable lactase derived from bacillus
US4110477A (en) 1977-05-13 1978-08-29 Kabushiki Kaisha Naruse Fermentation Laboratory Method for producing natto containing lactic acid bacteria
US5413960A (en) 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
JPH01199575A (ja) * 1988-02-04 1989-08-10 Rikagaku Kenkyusho 新規なサイクロマルトデキストリン・グルカノトランスフェラーゼ及びその製造法
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
IT1227154B (it) 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
AT391323B (de) 1989-03-10 1990-09-25 Jungbunzlauer Ag Mikroorganismus der species bacillus coagulans sowie ein verfahren zur herstellung von optisch reiner l(+)-milchsaeure
JPH02255620A (ja) * 1989-03-28 1990-10-16 Kazuo Tsubaki 抗白癬菌剤およびその製造方法、利用方法
DE4001611C1 (de) * 1990-01-20 1991-02-28 Skw Trostberg Ag, 8223 Trostberg, De
US5200336A (en) * 1990-07-02 1993-04-06 New England Biolabs, Inc. Restriction endonuclease obtainable foam bacillus coagulans and a process for producing the same
JP3172177B2 (ja) 1990-11-14 2001-06-04 イミュー プロダクツ ウェスターン オーストレイリア ピーティーワイ． リミテッド エミュー油から誘導した抗炎性混合物
IT1262927B (it) 1992-01-14 1996-07-22 Consiglio Nazionale Ricerche Batteri sporgenti e loro impiego come probiotici
IL101387A (en) * 1992-03-26 1999-11-30 Pharmos Ltd Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
WO1994011492A1 (en) 1992-11-12 1994-05-26 Chr. Hansen's Laboratory, Inc. Method of favorably modifying poultry intestinal microflora
US6103246A (en) * 1993-06-03 2000-08-15 Tisdale; Carrie J. Creams and lotions containing emu oil
SE508881C2 (sv) * 1994-03-02 1998-11-16 Ctc Medical Ab Preparat avsett att vid behandling av i tänder befintliga amalgamfyllningar och/eller vid inserering av nya amalgamfyllningar hämma frisättning av Hg från amalgamet och/eller oskadliggöra frisatt Hg
US5472713A (en) * 1994-11-23 1995-12-05 Elf Resources, Inc. Therapeutic uses of emu oil
US5744128A (en) * 1995-05-03 1998-04-28 Holick; Michael F. Use of emu oil for stimulating skin and hair growth
AUPN531195A0 (en) * 1995-09-11 1995-10-05 J.W. Broadbent Nominees Pty. Ltd. Lipid extract having anti-inflamatory activity
US5939394A (en) * 1996-01-18 1999-08-17 Fleming & Company Methods and compositions for the prevention and treatment of immunological disorders, inflammatory diseases and infections
US5698227A (en) 1996-07-23 1997-12-16 Rivlin; Daniel Compositions comprising lidocaine and emu oil and methods of use thereof
AU6046198A (en) 1997-01-31 1998-08-25 Kenneth Hoyt Use of oil from emu or rhea birds as trans-membrane carriers for delivery of drugs, peptides and vaccines
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
ATE493139T1 (de) * 1997-04-18 2011-01-15 Ganeden Biotech Inc Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen
US6399105B1 (en) * 1999-01-20 2002-06-04 Peter Donald Collin Sea cucumber carotenoid lipid fraction products and methods of use
EP1212093B1 (de) * 1999-08-26 2004-07-07 Ganeden Biotech, Inc. Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien

Also Published As

Publication number Publication date
US20080274153A1 (en) 2008-11-06
US20010033838A1 (en) 2001-10-25
US20060147544A1 (en) 2006-07-06
JP2003507437A (ja) 2003-02-25
CA2382670A1 (en) 2001-03-01
US6531126B2 (en) 2003-03-11
DE60012026T2 (de) 2004-12-30
WO2001013956A2 (en) 2001-03-01
US20040208860A1 (en) 2004-10-21
US7371407B2 (en) 2008-05-13
US20030170334A1 (en) 2003-09-11
EP1212093B1 (de) 2004-07-07
ES2221624T3 (es) 2005-01-01
WO2001013956A3 (en) 2001-10-04
DE60012026D1 (de) 2004-08-12
EP1212093A2 (de) 2002-06-12
US6733751B2 (en) 2004-05-11
US7048950B2 (en) 2006-05-23

Similar Documents

Publication Publication Date Title
ATE270558T1 (de) Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien
CN100374099C (zh) 抗微生物组合物
Lam et al. Recent advances on topical antimicrobials for skin and soft tissue infections and their safety concerns
Ghosh et al. Biological control of Alternaria alternata causing leaf spot disease of Aloe vera using two strains of rhizobacteria
WO2001013927A3 (en) Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof
EP1049378B1 (de) Antimikrobielle zusammensetzung
DE59511002D1 (de) Wirkstoffe für die behandlung der senilen xerosis und zubereitungen
ATE243042T1 (de) Biologisch aktive verbindungen aus ganoderma pfeifferi dms 13239
Jonathan et al. Studies on antimicrobial potentials of three Ganoderma species
DE69731477D1 (de) Mittel zur akne behandlung
ATE441423T1 (de) Verwendung von mastix und dessen ätherischen ílen zur verhinderung oder bekämpfung von mikrobieller infektionen
ATE183616T1 (de) Zusammensetzung und verfahren zur bekämpfung von pflanzenkrankheiten
DE59906392D1 (de) Hyaluronatlyase als penetrationsförderer in topischen mitteln
FI862609A0 (fi) Akne motverkande produkt.
YU13699A (sh) Primena 1-hidroksi-2-piridona za dobijanje leka za lečenje infekcija kože
PT90085A (pt) Processo para a preparacao de composicoes farmaceuticas contendo um complexo organico de ouro para aplicacao topica
EP1372603B1 (de) Topische zubereitung zur behandlung von zehennagelpilz
Blomstrand et al. Clinical investigation of use of an antimicrobial peptide hydrogel wound dressing on intact skin
Chatuphonprasert et al. Antibacterial and wound healing activity of Dipterocarpus alatus Crude extract against methicillin-resistant Staphylococcus aureus-induced superficial skin infection in mice
Maggi et al. The efficacy of 5% Sulfamylon® solution for the treatment of contaminated explanted human meshed skin grafts
SE7609181L (sv) Polyaminforeningar
CN110944669A (zh) 新的抗真菌组合物
BR0308734A (pt) Composto, composição farmacêutica, uso do composto, e, método para prevenir ou tratar infecção
EP4591851A1 (de) Präbiotische kosmetische zusammensetzungen, verwendung der präbiotischen kosmetischen zusammensetzungen, verwendung von babassuöl und kosmetisches verfahren
WO2024121383A1 (en) Novel compositions

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties